Logos Global Management’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-539,079	Closed	-$5.12M	–	49
2024 Q3	$5.12M	Hold	539,079	–	–	0.55%	40
2024 Q2	$6.72M	Buy	+539,079	New	+$6.72M	0.54%	37